Choose a Color

Contraceptive Implants: An Opportunity to Share Your Experiences With Colleagues (2008)


Jan 28-Feb 1, 2008
http://my.ibpinitiative.org/implants 

The purpose of this one-week forum was to review and discuss the latest guidance on contraceptive implants featured in Family Planning: A Global Handbook for Providers.

Discussion Statistics


Number of participants:  277
Number of participants' countries: 53   
Number of contributions: 46
% of contributions from developing countries: 56%
Number of countries contributing: 16

Contributing countries:
United States (15), Nigeria (1), Kenya (2), Uganda (1), Democratic Republic of the Congo (3), Australia (4), Brazil (2), Colombia (2), Guatemala (1), Malawi (1), Pakistan (3), Senegal (1), Cambodia (4), New Zealand (1), Sri Lanka (2), Timor-Leste (2)

Purpose and Objectives 
The purpose of this one-week forum was to review and discuss the latest guidance on contraceptive implants featured in Family Planning: A Global Handbook for Providers.

                                                       

Day 1. 

Questions:

  1. What are the main differences among the different implants?
  2. How effective are implants compared with other family planning methods?
  3. What technical (i.e., method-related, not program-related) questions, if any, do you or providers in your country have about implants?
  4. Does your clinic or facility offer contraceptive implants? If yes, which implants do you offer, and can you tell us about your experiences in providing implants?
  5. If your clinic does not offer contraceptive implants, can you tell us why not? Has the clinic ever considered offering them?
  6. Is your clinic or facility undergoing a transition from Norplant® to Implanon®, Jadelle® or Sino-Implant (II) ® (to be trademarked as Zarin® in African countries)? If so, how is the transition going? Have there been any challenges?
  7. Are Implanon®, Jadelle® or Sino-Implant (II) ® (to be trademarked as Zarin® in African countries) available in your facility? If so, how much must users pay for them? Are they provided at the same price for everyone, or are they given to low-income clients at a lower cost or free?

Full text daily digest         

                                                       

Day 2. 

Questions:

  1. Who can and cannot use implants? Can young women and older women use implants? Should heavy women avoid implants? Can women with HIV/AIDS use implants?
  2. Can a client start using implants immediately? Does she need a pelvic exam before she can have implants inserted?
  3. Do implants increase the risk of ectopic pregnancy?
  4. Is there are demand for contraceptive implants? Are your clients asking for them? If so, how have your clients learned of them?
  5. How does your clinic/program obtain implants? What are the barriers to availability and accessibility?
  6. What would you suggest to facilitate procurement? Ideally, how would you like to obtain implants?


Full text daily digest


Day 3.

Questions:

  1. What issues do you find with regards to removal, including access to removal?
  2. Does your clinic offer removal services? If not, do you refer your clients to other clinics?
  3. What is being done to guarantee that women can get their implants removed for any reason, whenever they want, and without cost? Some past Norplant programs experienced some controversy in this area.
  4. How much are local service delivery groups paying for implants?
  5. How much are they charging women to have an implant inserted?
  6. Are clinics in your country charging clients for removal; and if so, do you think this poses a real barrier to women who want their implant removed?
  7. In your opinion, how important is it ensure access to free removals?

Full text daily digest

                                             
Day 4.

Questions:

  1. What are the most commonly asked questions that clients have
about contraceptive implants?
  2. Women consider effectiveness the most important factor when they choose a contraceptive method, but also consider side effects and safety. What are the advantages of using implants?
  3. What should clients be told about insertion and removal of implants?
  4. In your experience, what are the most common reasons for women to either accept or reject implants?

Full text daily digest


Days 5.

Weekend contributions in response to previously asked questions. 

Full text daily digest


Post-forum survey results

% who have passed content to others - 26%

% who have or will use in their work - 75%

% very satisfied with forum content - 50%                                                           

References and resources

Related Resources & References in the community library: http://knowledge-gateway.org:80/Library.aspx?c=dfbb2d4b-d083-4008-98eb-fb9c59bf8a75

Population Council Materials

Population Reports and Companion INFO Reports

Scientific Journal Articles

The ACQUIRE Project/ENGENDERHEALTH Materials

Reports and publications

There is no text related to this title in the WORD document

Organizing groups

The International Consortium for Emergency Contraception (www.emergencycontraception.org), World Health Organization Department of Reproductive Health and Research (WHO/RHR) and the Partners of the Implementing Best Practices (IBP) Initiative, with assistance from The American Society for Emergency Contraception (ASEC)

Contributing experts/facilitators 

Martha Brady, M.S., Senior Associate, Population Council

Dawn Chin-Quee, PhD, MPH, scientist, FHI

Kelly Cleland, MPH, MPA, Princeton

Angel Foster, MD, PhD, Senior Associate, Ibis Reproductive Health

David Nolan, Director of Communication, Catholics for Choice Cristina Puig, MS, ICEC

Elizabeth Raymond, MD, MPH, gynecologist/ scientist, Gynuity Health Projects

David Turok, MD, University of Utah

Maggie Usher-Patel, Scientist, WHO/RHR, IBP Secretariat

Steering committee

Dawn Chin-Quee

Kelly Cleland

Angel Foster

Cristina Puig

Kathleen Schaffer

Elizabeth Westley

Other acknowledgements

American Society for Emergency Contraception

Catholics for Choice

CLAE (Latin American Consortium for EC)

ECAfrique

Family Violence Prevention Fund

Gynuity Health Projects

FHI

Population Council

Princeton University

Sexual Violence Research Initiative

FIGO

Ibis Reproductive Health

Moderators

Christina Fusco, RN, MSN, FNP-BC, MPH: WHO consultant

Deepa Ramchandran, MHS: WHO consultant

Katie Richey, MPH: Technical Officer, WHO/RHR